Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

GSK has stopped development of anti-TIGIT antibody belrestotug. | GSK has stopped development of anti-TIGIT antibody ...

Since launching in late 2023, Doctronic has provided 10 million quick, free and private medical consultations.

The failure is the latest stumble for a cancer drug class that hasn’t lived up to expectations. iTeos will begin a strategic ...